What are the medical, ethical implications of the world’s priciest drug?

In Dr. Robert Pearl’s column for Forbes entitled: “The $2.1 Million Question: What are the Medical, Ethical Implications of the World’s Priciest Drug?” He discusses the FDA approval of Zogensma, the world’s most expensive medication, priced at $2.125 million per patient and the growing debate over the rising price of medications. Read his column here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.

Leave a Reply